Two Sigma Investments’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.97M | Buy |
531,163
+69,706
| +15% | +$259K | ﹤0.01% | 1802 |
|
2025
Q1 | $1.49M | Buy |
461,457
+147,464
| +47% | +$476K | ﹤0.01% | 1879 |
|
2024
Q4 | $1.75M | Buy |
313,993
+208,021
| +196% | +$1.16M | ﹤0.01% | 1751 |
|
2024
Q3 | $1.15M | Buy |
105,972
+78,449
| +285% | +$848K | ﹤0.01% | 1987 |
|
2024
Q2 | $578K | Sell |
27,523
-3,878
| -12% | -$81.4K | ﹤0.01% | 2230 |
|
2024
Q1 | $1M | Buy |
+31,401
| New | +$1M | ﹤0.01% | 1898 |
|
2023
Q4 | – | Sell |
-101,863
| Closed | -$1.3M | – | 3130 |
|
2023
Q3 | $1.3M | Sell |
101,863
-83,276
| -45% | -$1.06M | ﹤0.01% | 1720 |
|
2023
Q2 | $3.35M | Sell |
185,139
-15,744
| -8% | -$284K | 0.01% | 1064 |
|
2023
Q1 | $3.45M | Buy |
200,883
+46,909
| +30% | +$806K | 0.01% | 1020 |
|
2022
Q4 | $3.42M | Buy |
153,974
+137,525
| +836% | +$3.05M | 0.01% | 1006 |
|
2022
Q3 | $132K | Sell |
16,449
-29,546
| -64% | -$237K | ﹤0.01% | 2141 |
|
2022
Q2 | $321K | Buy |
45,995
+30,295
| +193% | +$211K | ﹤0.01% | 1941 |
|
2022
Q1 | $237K | Sell |
15,700
-55,147
| -78% | -$832K | ﹤0.01% | 2253 |
|
2021
Q4 | $1.55M | Buy |
+70,847
| New | +$1.55M | ﹤0.01% | 1447 |
|